Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.

Identifieur interne : 000610 ( PubMed/Checkpoint ); précédent : 000609; suivant : 000611

Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.

Auteurs : Ahmed A. Al-Qahtani [Arabie saoudite] ; Konstantina Lyroni [Grèce] ; Marina Aznaourova [Grèce] ; Melpomeni Tseliou [Grèce] ; Mashael R. Al-Anazi [Arabie saoudite] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; Saad Alkahtani [Arabie saoudite] ; George Sourvinos [Grèce] ; Christos Tsatsanis [Grèce]

Source :

RBID : pubmed:28118607

Descripteurs français

English descriptors

Abstract

Middle East Respiratory Syndrome Corona Virus (MERS-CoV) is transmitted via the respiratory tract and causes severe Acute Respiratory Distress Syndrome by infecting lung epithelial cells and macrophages. Macrophages can readily recognize the virus and eliminate it. MERS-CoV infects cells via its Spike (S) glycoprotein that binds on Dipeptidyl-Peptidase 4 (DPP4) receptor present on macrophages. Whether this Spike/DPP4 association affects macrophage responses remains unknown. Herein we demonstrated that infection of macrophages with lentiviral particles pseudotyped with MERS-CoV S glycoprotein results in suppression of macrophage responses since it reduced the capacity of macrophages to produce TNFα and IL-6 in naive and LPS-activated THP-1 macrophages and augmented LPS-induced production of the immunosuppressive cytokine IL-10. MERS-CoV S glycoprotein induced the expression of the negative regulator of TLR signaling IRAK-M as well as of the transcriptional repressor PPARγ. Inhibition of DPP4 by its inhibitor sitagliptin or siRNA abrogated the effects of MERS-CoV S glycoprotein on IRAK-M, PPARγ and IL-10, confirming that its immunosuppressive effects were mediated by DPP4 receptor. The effect was observed both in THP-1 macrophages and human primary peripheral blood monocytes. These findings support a DPP4-mediated suppressive action of MERS-CoV in macrophages and suggest a potential target for effective elimination of its pathogenicity.

DOI: 10.18632/oncotarget.14754
PubMed: 28118607


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28118607

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.</title>
<author>
<name sortKey="Al Qahtani, Ahmed A" sort="Al Qahtani, Ahmed A" uniqKey="Al Qahtani A" first="Ahmed A" last="Al-Qahtani">Ahmed A. Al-Qahtani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lyroni, Konstantina" sort="Lyroni, Konstantina" uniqKey="Lyroni K" first="Konstantina" last="Lyroni">Konstantina Lyroni</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Aznaourova, Marina" sort="Aznaourova, Marina" uniqKey="Aznaourova M" first="Marina" last="Aznaourova">Marina Aznaourova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tseliou, Melpomeni" sort="Tseliou, Melpomeni" uniqKey="Tseliou M" first="Melpomeni" last="Tseliou">Melpomeni Tseliou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Virology, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Al Anazi, Mashael R" sort="Al Anazi, Mashael R" uniqKey="Al Anazi M" first="Mashael R" last="Al-Anazi">Mashael R. Al-Anazi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Al Ahdal, Mohammed N" sort="Al Ahdal, Mohammed N" uniqKey="Al Ahdal M" first="Mohammed N" last="Al-Ahdal">Mohammed N. Al-Ahdal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alkahtani, Saad" sort="Alkahtani, Saad" uniqKey="Alkahtani S" first="Saad" last="Alkahtani">Saad Alkahtani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Zoology Department, College of Science, King Saud University, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sourvinos, George" sort="Sourvinos, George" uniqKey="Sourvinos G" first="George" last="Sourvinos">George Sourvinos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Virology, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tsatsanis, Christos" sort="Tsatsanis, Christos" uniqKey="Tsatsanis C" first="Christos" last="Tsatsanis">Christos Tsatsanis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28118607</idno>
<idno type="pmid">28118607</idno>
<idno type="doi">10.18632/oncotarget.14754</idno>
<idno type="wicri:Area/PubMed/Corpus">000615</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000615</idno>
<idno type="wicri:Area/PubMed/Curation">000615</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000615</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000610</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000610</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.</title>
<author>
<name sortKey="Al Qahtani, Ahmed A" sort="Al Qahtani, Ahmed A" uniqKey="Al Qahtani A" first="Ahmed A" last="Al-Qahtani">Ahmed A. Al-Qahtani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lyroni, Konstantina" sort="Lyroni, Konstantina" uniqKey="Lyroni K" first="Konstantina" last="Lyroni">Konstantina Lyroni</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Aznaourova, Marina" sort="Aznaourova, Marina" uniqKey="Aznaourova M" first="Marina" last="Aznaourova">Marina Aznaourova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tseliou, Melpomeni" sort="Tseliou, Melpomeni" uniqKey="Tseliou M" first="Melpomeni" last="Tseliou">Melpomeni Tseliou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Virology, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Al Anazi, Mashael R" sort="Al Anazi, Mashael R" uniqKey="Al Anazi M" first="Mashael R" last="Al-Anazi">Mashael R. Al-Anazi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Al Ahdal, Mohammed N" sort="Al Ahdal, Mohammed N" uniqKey="Al Ahdal M" first="Mohammed N" last="Al-Ahdal">Mohammed N. Al-Ahdal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center</wicri:regionArea>
<wicri:noRegion>King Faisal Specialist Hospital and Research Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alkahtani, Saad" sort="Alkahtani, Saad" uniqKey="Alkahtani S" first="Saad" last="Alkahtani">Saad Alkahtani</name>
<affiliation wicri:level="1">
<nlm:affiliation>Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Zoology Department, College of Science, King Saud University, Riyadh</wicri:regionArea>
<wicri:noRegion>Riyadh</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sourvinos, George" sort="Sourvinos, George" uniqKey="Sourvinos G" first="George" last="Sourvinos">George Sourvinos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Virology, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tsatsanis, Christos" sort="Tsatsanis, Christos" uniqKey="Tsatsanis C" first="Christos" last="Tsatsanis">Christos Tsatsanis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion</wicri:regionArea>
<wicri:noRegion>Heraklion</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Oncotarget</title>
<idno type="eISSN">1949-2553</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Dipeptidyl Peptidase 4 (genetics)</term>
<term>Dipeptidyl Peptidase 4 (metabolism)</term>
<term>Dipeptidyl-Peptidase IV Inhibitors (pharmacology)</term>
<term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>Interleukin-1 Receptor-Associated Kinases (genetics)</term>
<term>Interleukin-1 Receptor-Associated Kinases (metabolism)</term>
<term>Interleukin-10 (metabolism)</term>
<term>Interleukin-6 (metabolism)</term>
<term>Macrophage Activation (drug effects)</term>
<term>Macrophages (drug effects)</term>
<term>Macrophages (enzymology)</term>
<term>Macrophages (immunology)</term>
<term>Macrophages (virology)</term>
<term>Middle East Respiratory Syndrome Coronavirus (genetics)</term>
<term>Middle East Respiratory Syndrome Coronavirus (immunology)</term>
<term>Middle East Respiratory Syndrome Coronavirus (metabolism)</term>
<term>Middle East Respiratory Syndrome Coronavirus (pathogenicity)</term>
<term>PPAR gamma (genetics)</term>
<term>PPAR gamma (metabolism)</term>
<term>RNA Interference</term>
<term>Signal Transduction</term>
<term>Spike Glycoprotein, Coronavirus (genetics)</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>THP-1 Cells</term>
<term>Transfection</term>
<term>Tumor Necrosis Factor-alpha (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation des macrophages ()</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (génétique)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (métabolisme)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (pathogénicité)</term>
<term>Dipeptidyl peptidase 4 (génétique)</term>
<term>Dipeptidyl peptidase 4 (métabolisme)</term>
<term>Facteur de nécrose tumorale alpha (métabolisme)</term>
<term>Glycoprotéine de spicule des coronavirus (génétique)</term>
<term>Glycoprotéine de spicule des coronavirus (métabolisme)</term>
<term>Humains</term>
<term>Inhibiteurs de la dipeptidyl-peptidase IV (pharmacologie)</term>
<term>Interactions hôte-pathogène</term>
<term>Interférence par ARN</term>
<term>Interleukin-1 Receptor-Associated Kinases (génétique)</term>
<term>Interleukin-1 Receptor-Associated Kinases (métabolisme)</term>
<term>Interleukine-10 (métabolisme)</term>
<term>Interleukine-6 (métabolisme)</term>
<term>Macrophages ()</term>
<term>Macrophages (enzymologie)</term>
<term>Macrophages (immunologie)</term>
<term>Macrophages (virologie)</term>
<term>Récepteur PPAR gamma (génétique)</term>
<term>Récepteur PPAR gamma (métabolisme)</term>
<term>Transduction du signal</term>
<term>Transfection</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Dipeptidyl Peptidase 4</term>
<term>Interleukin-1 Receptor-Associated Kinases</term>
<term>PPAR gamma</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Dipeptidyl Peptidase 4</term>
<term>Interleukin-1 Receptor-Associated Kinases</term>
<term>Interleukin-10</term>
<term>Interleukin-6</term>
<term>PPAR gamma</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Dipeptidyl-Peptidase IV Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Macrophage Activation</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Dipeptidyl peptidase 4</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Interleukin-1 Receptor-Associated Kinases</term>
<term>Récepteur PPAR gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Macrophages</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Dipeptidyl peptidase 4</term>
<term>Facteur de nécrose tumorale alpha</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Interleukin-1 Receptor-Associated Kinases</term>
<term>Interleukine-10</term>
<term>Interleukine-6</term>
<term>Récepteur PPAR gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de la dipeptidyl-peptidase IV</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>RNA Interference</term>
<term>Signal Transduction</term>
<term>THP-1 Cells</term>
<term>Transfection</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation des macrophages</term>
<term>Humains</term>
<term>Interactions hôte-pathogène</term>
<term>Interférence par ARN</term>
<term>Macrophages</term>
<term>Transduction du signal</term>
<term>Transfection</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Middle East Respiratory Syndrome Corona Virus (MERS-CoV) is transmitted via the respiratory tract and causes severe Acute Respiratory Distress Syndrome by infecting lung epithelial cells and macrophages. Macrophages can readily recognize the virus and eliminate it. MERS-CoV infects cells via its Spike (S) glycoprotein that binds on Dipeptidyl-Peptidase 4 (DPP4) receptor present on macrophages. Whether this Spike/DPP4 association affects macrophage responses remains unknown. Herein we demonstrated that infection of macrophages with lentiviral particles pseudotyped with MERS-CoV S glycoprotein results in suppression of macrophage responses since it reduced the capacity of macrophages to produce TNFα and IL-6 in naive and LPS-activated THP-1 macrophages and augmented LPS-induced production of the immunosuppressive cytokine IL-10. MERS-CoV S glycoprotein induced the expression of the negative regulator of TLR signaling IRAK-M as well as of the transcriptional repressor PPARγ. Inhibition of DPP4 by its inhibitor sitagliptin or siRNA abrogated the effects of MERS-CoV S glycoprotein on IRAK-M, PPARγ and IL-10, confirming that its immunosuppressive effects were mediated by DPP4 receptor. The effect was observed both in THP-1 macrophages and human primary peripheral blood monocytes. These findings support a DPP4-mediated suppressive action of MERS-CoV in macrophages and suggest a potential target for effective elimination of its pathogenicity.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28118607</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1949-2553</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2017</Year>
<Month>Feb</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>Oncotarget</Title>
<ISOAbbreviation>Oncotarget</ISOAbbreviation>
</Journal>
<ArticleTitle>Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.</ArticleTitle>
<Pagination>
<MedlinePgn>9053-9066</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.14754</ELocationID>
<Abstract>
<AbstractText>Middle East Respiratory Syndrome Corona Virus (MERS-CoV) is transmitted via the respiratory tract and causes severe Acute Respiratory Distress Syndrome by infecting lung epithelial cells and macrophages. Macrophages can readily recognize the virus and eliminate it. MERS-CoV infects cells via its Spike (S) glycoprotein that binds on Dipeptidyl-Peptidase 4 (DPP4) receptor present on macrophages. Whether this Spike/DPP4 association affects macrophage responses remains unknown. Herein we demonstrated that infection of macrophages with lentiviral particles pseudotyped with MERS-CoV S glycoprotein results in suppression of macrophage responses since it reduced the capacity of macrophages to produce TNFα and IL-6 in naive and LPS-activated THP-1 macrophages and augmented LPS-induced production of the immunosuppressive cytokine IL-10. MERS-CoV S glycoprotein induced the expression of the negative regulator of TLR signaling IRAK-M as well as of the transcriptional repressor PPARγ. Inhibition of DPP4 by its inhibitor sitagliptin or siRNA abrogated the effects of MERS-CoV S glycoprotein on IRAK-M, PPARγ and IL-10, confirming that its immunosuppressive effects were mediated by DPP4 receptor. The effect was observed both in THP-1 macrophages and human primary peripheral blood monocytes. These findings support a DPP4-mediated suppressive action of MERS-CoV in macrophages and suggest a potential target for effective elimination of its pathogenicity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Al-Qahtani</LastName>
<ForeName>Ahmed A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, School of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lyroni</LastName>
<ForeName>Konstantina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aznaourova</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tseliou</LastName>
<ForeName>Melpomeni</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Anazi</LastName>
<ForeName>Mashael R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Ahdal</LastName>
<ForeName>Mohammed N</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, School of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alkahtani</LastName>
<ForeName>Saad</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sourvinos</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Virology, Medical School, University of Crete, Heraklion, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsatsanis</LastName>
<ForeName>Christos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Oncotarget</MedlineTA>
<NlmUniqueID>101532965</NlmUniqueID>
<ISSNLinking>1949-2553</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047495">PPAR gamma</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>130068-27-8</RegistryNumber>
<NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C507771">IRAK3 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D053592">Interleukin-1 Receptor-Associated Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.14.5</RegistryNumber>
<NameOfSubstance UI="C042807">DPP4 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.14.5</RegistryNumber>
<NameOfSubstance UI="D018819">Dipeptidyl Peptidase 4</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D018819" MajorTopicYN="N">Dipeptidyl Peptidase 4</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053592" MajorTopicYN="N">Interleukin-1 Receptor-Associated Kinases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008262" MajorTopicYN="Y">Macrophage Activation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047495" MajorTopicYN="N">PPAR gamma</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000074084" MajorTopicYN="N">THP-1 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">DPP4</Keyword>
<Keyword MajorTopicYN="N">IRAK-M</Keyword>
<Keyword MajorTopicYN="N">Immune response</Keyword>
<Keyword MajorTopicYN="N">Immunity</Keyword>
<Keyword MajorTopicYN="N">Immunology and Microbiology Section</Keyword>
<Keyword MajorTopicYN="N">MERS CoV</Keyword>
<Keyword MajorTopicYN="N">cytokines</Keyword>
<Keyword MajorTopicYN="N">macrophages</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>07</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>01</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>1</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>1</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28118607</ArticleId>
<ArticleId IdType="pii">14754</ArticleId>
<ArticleId IdType="doi">10.18632/oncotarget.14754</ArticleId>
<ArticleId IdType="pmc">PMC5354714</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Nov;87(21):11950-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23986586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Aug;84(15):7703-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20484496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Immunol. 2008 May;45(10):2970-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18336909</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 Feb 1;198(3):1297-1307</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28011933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2013 Aug;23(8):986-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23835475</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2013 Jan;62(1):149-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22936179</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2014 Feb 18;5(1):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24549846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 May 1;209(9):1331-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24065148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Feb;88(3):1834-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24257613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2013 Jun 1;207(11):1743-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23532101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2014 Jan 1;192(1):394-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24277697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Aug 8;500(7461):227-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23831647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2014 Apr 03;10(4):e1004053</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24699679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 May 15;182(10):6444-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19414798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Mar 14;495(7440):176-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23486053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2014;5:3067</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24473083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2015 Dec 15;195(12):5750-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26538391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2015 Jun 25;20(25):14-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26132768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2012 Oct 1;303(7):L608-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22886503</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2015 Apr;89(7):3859-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25609809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2016 Mar 15;213(6):904-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26203058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2010 May;10 (5):365-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20414208</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2013 Sep;13(9):745-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23782859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2014 Dec 19;194:200-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25451066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Retrovirology. 2014 Oct 17;11:88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25323821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2009 Oct;5(10):e1000633</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19851458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2016 Feb;97(2):344-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26602089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Aug 1;369(5):466-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23902487</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26124093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2013 Jul 1;305(1):L64-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23624787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2012 Nov 20;3(6):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lupus. 2012 Oct;21(11):1166-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22634523</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):113-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25072612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Aug;87(16):9379-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23785207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 May;87(10):5502-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23468491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunology. 2015 Aug;145(4):476-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25762305</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Arabie saoudite</li>
<li>Grèce</li>
</country>
</list>
<tree>
<country name="Arabie saoudite">
<noRegion>
<name sortKey="Al Qahtani, Ahmed A" sort="Al Qahtani, Ahmed A" uniqKey="Al Qahtani A" first="Ahmed A" last="Al-Qahtani">Ahmed A. Al-Qahtani</name>
</noRegion>
<name sortKey="Al Ahdal, Mohammed N" sort="Al Ahdal, Mohammed N" uniqKey="Al Ahdal M" first="Mohammed N" last="Al-Ahdal">Mohammed N. Al-Ahdal</name>
<name sortKey="Al Anazi, Mashael R" sort="Al Anazi, Mashael R" uniqKey="Al Anazi M" first="Mashael R" last="Al-Anazi">Mashael R. Al-Anazi</name>
<name sortKey="Alkahtani, Saad" sort="Alkahtani, Saad" uniqKey="Alkahtani S" first="Saad" last="Alkahtani">Saad Alkahtani</name>
</country>
<country name="Grèce">
<noRegion>
<name sortKey="Lyroni, Konstantina" sort="Lyroni, Konstantina" uniqKey="Lyroni K" first="Konstantina" last="Lyroni">Konstantina Lyroni</name>
</noRegion>
<name sortKey="Aznaourova, Marina" sort="Aznaourova, Marina" uniqKey="Aznaourova M" first="Marina" last="Aznaourova">Marina Aznaourova</name>
<name sortKey="Sourvinos, George" sort="Sourvinos, George" uniqKey="Sourvinos G" first="George" last="Sourvinos">George Sourvinos</name>
<name sortKey="Tsatsanis, Christos" sort="Tsatsanis, Christos" uniqKey="Tsatsanis C" first="Christos" last="Tsatsanis">Christos Tsatsanis</name>
<name sortKey="Tseliou, Melpomeni" sort="Tseliou, Melpomeni" uniqKey="Tseliou M" first="Melpomeni" last="Tseliou">Melpomeni Tseliou</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000610 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000610 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28118607
   |texte=   Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28118607" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021